Introduction. Considering the very important role of adiponectin and leptin in atherogenesis, it is important to study their relationship with other important factors in establishing the cardiometabolic risk: hyperglycemia and serum lipids.Patients and Methods. There were studied 79 subjects (s), aged 59± 9 years, divided into 3 groups according to body mass index (BMI): group I with BMI<25 kg/m 2 -19 s, group II with BMI 25-30 kg/m 2 -30s, and group III with BMI >30 kg/m 2 -30 s. In all subjects the plasmatic levels of adiponectin, leptin and other cardiometabolic risk factors: blood glucose, total cholesterol, triglycerides, high density cholesterol, low density cholesterol were measured.Results. Considering the values of adiponectin and leptin in the three groups, adiponectin was significantly increased (14355±9120.40 vs 5889.167±6278.963 ng/mL, p=0.015) and leptin significantly decreased (7212±7428.45 vs 9235.81±10988.66 pg/mL, p=0.03), in group I in comparison with group II+III. Adiponectin and leptin were not significantly different in subjects with fasting glucose less or more than 110 mg/dL and the same insignificant difference was registered for both adipokines between diabetic and non diabetic subjects. Considering the plasma lipid fractions, it was registered an inverse significant correlation between adiponectin and total cholesterol, respectively LDL cholesterol, and a positive correlation with HDL cholesterol; leptin was inversely correlated with HDL cholesterol, but not with LDL cholesterol or total cholesterol.Conclusion. In the present study, the plasmatic values of adipokines (adiponectin and leptin) were correlated only to the BMI values (obesity) and respectively to the lipidic fractions. No correlation was registered with diabetes or impaired fasting glucose.